Researchers refine in vitro test that will reduce the risk of "first in humans" drug trials.
Mayor
Susan
S
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D002478:Cells, Cultured; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004847:Epithelial Cells; D006805:Human Experimentation; D006801:Humans; D040242:Risk Reduction Behavior; D018675:Toxicity Tests / Q000379:methods*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C509303:TGN-1412